论文部分内容阅读
目的：观察黄芪注射液治疗肝炎后肝硬化腹水的疗效。方法：将71例肝炎后肝硬化腹水患者随机分成对照组(西药综合疗法)及治疗组(西药综合疗法+黄芪注射液)，观察治疗前后临床症状和体征及血清胆红素(T-BIL)、血清白蛋白(ALB)、谷丙转氨酶(ALT)的变化。结果：治疗组临床症状和体征改善较快；治疗组血清胆红素下降幅度和白蛋白上升幅度均优于对照组。结论：黄芪注射液能明显改善患者症状，改善肝硬化患者肝脏蛋白质的合成功能，能保护肝细胞膜，促进肝脏功能的恢复。
Objective: To observe the therapeutic effect of Astragalus injection on cirrhotic ascites after hepatitis. Methods: Seventy-one patients with posthepatitic cirrhosis and ascites were randomly divided into control group (western medicine combined therapy) and treatment group (Western combined therapy + astragalus injection). The clinical symptoms and signs, serum bilirubin (T-BIL) , Serum albumin (ALB), alanine aminotransferase (ALT) changes. Results: The clinical symptoms and signs of the treatment group improved rapidly. The decrease of serum bilirubin and albumin in the treatment group were better than those in the control group. Conclusion: Astragalus injection can significantly improve the symptoms of patients with liver cirrhosis to improve the synthesis of liver function, to protect the liver cell membrane, and promote the recovery of liver function.